Abbott Laboratories (XSWX:ABT) Marketable Securities: CHF387 Mil (As of Mar. 2026)


XSWX:ABT Abbott Laboratories XSWX:ABT
76 GF Score
Price CHF76.00
GF Value CHF103.55
View Full Analysis

What is Abbott Laboratories Marketable Securities?

Abbott Laboratories XSWX:ABT 76 Marketable Securities is CHF387 Mil as of Mar. 2026. GuruFocus rates XSWX:ABT with a GF Score™ of 76/100 and a GF Value™ of CHF103.55.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Abbott Laboratories's Marketable Securities for the quarter that ended in Mar. 2026 was CHF387 Mil.

Abbott Laboratories's annual Marketable Securities declined from Dec. 2023 (CHF331 Mil) to Dec. 2024 (CHF313 Mil) but then increased from Dec. 2024 (CHF313 Mil) to Dec. 2025 (CHF332 Mil).

Abbott Laboratories  (XSWX:ABT) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Abbott Laboratories Marketable Securities Related Terms

Abbott Laboratories Marketable Securities Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories Marketable Securities Chart

Abbott Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 414.45 268.30 331.22 312.95 332.31

Abbott Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 275.68 269.17 176.73 332.31 387.35
XSWX:ABT
76GF Score
Abbott Laboratories XSWX:ABT
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of CHF387 Mil mean?
Abbott Laboratories (XSWX:ABT) has a Marketable Securities of CHF387 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Abbott Laboratories and its competitors.
Is Abbott Laboratories' Marketable Securities too high?
Abbott Laboratories' current Marketable Securities is CHF387 Mil. Overall, Abbott Laboratories has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Marketable Securities compare to SYK and MDT?
Abbott Laboratories' Marketable Securities of CHF387 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Abbott Laboratories and its competitors. Abbott Laboratories's current Marketable Securities is CHF387 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Abbott Laboratories (XSWX:ABT) has a current Marketable Securities of CHF387 Mil. The stock's GF Value™ is CHF103.55, compared to a current price of CHF76.00 — trading 26.6% below its estimated fair value. The current Marketable Securities is CHF387 Mil. Abbott Laboratories' overall GF Score™ is 76/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Abbott Laboratories (XSWX:ABT), the current Marketable Securities is CHF387 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (XSWX:ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of CHF76.00 is trading 26.6% below its estimated GF Value™ of CHF103.55.

Key valuation signals for XSWX:ABT:

  • Marketable Securities: CHF387 Mil
  • GF Value™: CHF103.55 vs. price of CHF76.00 (26.6% below fair value)
  • GF Score™: 76/100

No single metric tells the full story. See the XSWX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
76GF Score

Get the complete analysis for XSWX:ABT

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF76.00
Price
CHF103.55
GF Value